Compass Therapeutics Inc
(CMPX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,580 | N/A | -27 | -17 | -9 |
| Depreciation Amortization | 1,060 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -1,280 | N/A | N/A | N/A | N/A |
| Other Working Capital | -1,517 | N/A | 4 | 4 | 1 |
| Other Operating Activity | 1,871 | 0 | 0 | 0 | 0 |
| Operating Cash Flow | $-19,446 | $N/A | $-23 | $-13 | $-8 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -254 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-254 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 28 | 15 | 15 |
| Financing Cash Flow | $N/A | $N/A | $28 | $15 | $15 |
| Beginning Cash Position | 57,773 | N/A | N/A | N/A | N/A |
| End Cash Position | 38,073 | N/A | 5 | 2 | 7 |
| Net Cash Flow | $-19,700 | $N/A | $5 | $2 | $7 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,446 | N/A | -23 | -13 | -8 |
| Capital Expenditure | -254 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -19,700 | 0 | -23 | -13 | -8 |